Growth hormone deficiency
Norditropin® products
NordiCare® support
Insurance assistance 
Patient programs 
Resources
FAQs
Prescribing Information
Instructions for Use
Important Safety Information
    

NordiCare® patient programs

NordiCare® JumpStart—providing medication on a short-term basis for those in need
•  Through NordiCare®, patients with unresolved insurance reimbursement issues can receive Norditropin® on a short-term basis
•  Your NordiCare® Case Specialist will consult with your or your child's doctor to determine whether treatment should begin right away or can start at a later date
•  While your NordiCare® Case Specialist verifies insurance coverage or seeks alternative sources of coverage, you or your child may be eligible to receive, at no-charge, a supply of Norditropin® through NordiCare® for up to 2 months
•  If your NordiCare® Case Specialist is not able to obtain reimbursement coverage, your case will be reviewed to determine whether you or your child qualifies for ongoing medication support via NordiCare®

NordiCare® Patient Access Program—ongoing medication support for those in greatest need
•  NordiCare® helps patients get their medication if insurance coverage cannot be obtained
•  Eligible patients will receive Norditropin® for up to 6 months
•  At the end of 6 months, your personal NordiCare® Case Specialist will contact you to evaluate your situation and determine if you or your child still need assistance

To qualify for long-term medication support via NordiCare®, certain financial eligibility requirements must be met. Your eligibility may be reviewed every year and is based on your family's annual income, geographic location, and number of household members. If there are any changes in your family's financial status, you must notify your NordiCare® Case Specialist.

Important Safety Information

Remember, your doctor is the main source of information about you and your health. Please consult your doctor if you have any questions about your health or your medication.

Norditropin® (somatropin [rDNA origin] injection) is used to treat children with growth failure caused by very low or no production of growth hormone. It is also used to treat adults who do not make enough growth hormone.

Do not use Norditropin® if you have any of the following conditions: an allergy to phenol or any other ingredients in the medicine; active cancer or other forms of tumor; acute critical illness due to certain types of heart or abdomen surgery, trauma, or acute respiratory failure.

Children should not use Norditropin® if they have any of the following conditions: closed epiphyses (closed bone growth plates), Prader-Willi syndrome with severe obesity, or Prader-Willi syndrome with significant respiratory impairment.

Be sure to tell your doctor if you have diabetes mellitus; have had cancer or other forms of tumor; are pregnant, planning to be pregnant or are breastfeeding; or if you have had a kidney transplant.

Be sure to tell your doctor about all medications you are taking especially if they are: a glucocorticoid medication such as hydrocortisone or cortisone acetate, thyroid hormone, insulin and/or oral diabetes medicines, drugs metabolized by the liver (for example, corticosteroids, sex steroids, anticonvulsants, cyclosporine), or oral estrogen replacement.

Adult height can be influenced if you are on Norditropin® for growth failure and at the same time using glucocorticoids or thyroid hormone.

If you are treated with insulin and/or oral diabetes medicines, the dose of your insulin/oral diabetes medicines may need to be adjusted.

Side effects are usually mild and temporary. Side effects may include headaches, muscle pain, joint stiffness, weakness, high blood sugar (hyperglycemia), sugar in your urine (glucosuria), swollen hands and feet due to fluid retention, and redness and itching in the area you inject.

If you have any of these symptoms, discuss them with your doctor.

If you have headaches, eyesight problems, nausea and/or vomiting, these may be symptoms of raised pressure in the brain. Contact your doctor right away.

In very rare cases children treated with somatropin have experienced pain in the hip or knee or a limp. These symptoms may be caused by a slippage of the growth plate in the hip (slipped capital femoral epiphysis).

Scoliosis (curvature of the spine) can occur in children who experience rapid growth. Because growth hormone increases growth rate, children should be monitored for progression of scoliosis.

Thyroid function tests should be performed periodically.

Skin lesions should be checked carefully for any unusual changes.

Talk to your doctor if you think you have any of these conditions.
Important Safety Information | Prescribing Information | Disclaimer | Privacy Statement
Site Map | Contact Us | Print This Page
Remember, your doctor is the primary source of information regarding you and your health. Please consult your doctor if you have any questions about your health or medication.
The ANSWER Program® Registry, Autocover®, NordiCare®, NordiPen®, NordiPenMate®, Norditropin®, Norditropin NordiFlex®, and NovoFine® are registered trademarks of Novo Nordisk A/S, Denmark.
©2007 Novo Nordisk Inc. All rights reserved.